Autism Research Review International Newsletter

The Autism Research Institute has published a quarterly newsletter, Autism Research Review International (ARRI), since 1987. The ARRI has received worldwide praise for its thoroughness and objectivity in reporting the current developments in biomedical and educational research. The latest findings are gleaned from a computer search of the 25,000 scientific and medical articles published every week.

Some of the titles from the latest issue of the ARRI include:

• Autism rates dropping in California--is phase-out of thimerosal the reason?
• New therapy: Low-dose naltrexone for immunomodulation, written by Jaquelyn McCandless, M.D.
• Wakefield: intestinal abnormalities confirmed
• Mounting evidence points to oxidative stress as a culprit in autism spectrum disorder
• von Economo neurons: a key to autism?
• Immediate drug therapy doesn't reduce long-term seizure risk
• Thimerosal damage to neurons identified
• Sensory therapy highly successful for ADHD
• Profiles aid in picking right intervention
• New British study confirms rise in autism
• Videos prove validity of regressive autism

A one-year subscription to the ARRI is $18 (U.S. funds; $20 outside the U.S.). Each issue is sent via first class mail. Back issues of the ARRI (from 1987) can be purchased for $12 per year.

If you would like to subscribe to the ARRI, or to receive a free sample issue, see ARI Information Request Form.

You can also subscribe to the ARRI and/or purchase back issues using Pay Pal.

© copyright 2005, 2006 Autism Research Institute